TERM ID="NYU_TERM_1" STRING="B-lymphocytes" FREQUENCY=1 START=1129 END=1142 LEMMA="B-LYMPHOCYTE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="HCV" FREQUENCY=4 START=4 END=7 LEMMA="HCV" LEMMA_FREQUENCY=4 HEAD_TERM="HCV" HEAD_LEMMA="HCV" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_3" STRING="HCV" FREQUENCY=4 START=521 END=524 LEMMA="HCV" LEMMA_FREQUENCY=4 HEAD_TERM="HCV" HEAD_LEMMA="HCV" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_4" STRING="HCV" FREQUENCY=4 START=1297 END=1300 LEMMA="HCV" LEMMA_FREQUENCY=4 HEAD_TERM="HCV" HEAD_LEMMA="HCV" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_5" STRING="HCV" FREQUENCY=4 START=1612 END=1615 LEMMA="HCV" LEMMA_FREQUENCY=4 HEAD_TERM="HCV" HEAD_LEMMA="HCV" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_6" STRING="HCV-related" FREQUENCY=1 START=1501 END=1512 LEMMA="HCV-RELATED" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="HCV-related lymphoma" FREQUENCY=1 START=1717 END=1737 LEMMA="HCV-RELATED LYMPHOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="Preliminary results" FREQUENCY=1 START=1164 END=1183 LEMMA="PRELIMINARY RESULT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="aggressive chemotherapy treatments" FREQUENCY=1 START=1556 END=1590 LEMMA="AGGRESSIVE CHEMOTHERAPY TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="anti-viral" FREQUENCY=1 START=1884 END=1894 LEMMA="ANTI-VIRAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="antiviral agents" FREQUENCY=1 START=650 END=666 LEMMA="ANTIVIRAL AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="biological agents" FREQUENCY=1 START=1255 END=1272 LEMMA="BIOLOGICAL AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="biological drugs" FREQUENCY=1 START=589 END=605 LEMMA="BIOLOGICAL DRUG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="complications" FREQUENCY=1 START=780 END=793 LEMMA="COMPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="contraindication" FREQUENCY=1 START=553 END=569 LEMMA="CONTRAINDICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="cryoglobulinemia" FREQUENCY=1 START=1519 END=1535 LEMMA="CRYOGLOBULINEMIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="cryoglobulinemia Mixed cryoglobulinemia" FREQUENCY=1 START=42 END=81 LEMMA="CRYOGLOBULINEMIA MIXED CRYOGLOBULINEMIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="cytokines" FREQUENCY=1 START=623 END=632 LEMMA="CYTOKINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="cytotoxic therapy" FREQUENCY=1 START=1899 END=1916 LEMMA="CYTOTOXIC THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="empirical observations" FREQUENCY=1 START=1386 END=1408 LEMMA="EMPIRICAL OBSERVATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="expectations" FREQUENCY=1 START=710 END=722 LEMMA="EXPECTATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="immunosuppressives" FREQUENCY=1 START=422 END=440 LEMMA="IMMUNOSUPPRESSIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="investigators" FREQUENCY=1 START=1032 END=1045 LEMMA="INVESTIGATOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="lymphoproliferation" FREQUENCY=1 START=939 END=958 LEMMA="LYMPHOPROLIFERATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="multi-step" FREQUENCY=1 START=1863 END=1873 LEMMA="MULTI-STEP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="obtaining disease remission" FREQUENCY=1 START=372 END=399 LEMMA="OBTAINING DISEASE REMISSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="peripheral neuropathies" FREQUENCY=1 START=908 END=931 LEMMA="PERIPHERAL NEUROPATHY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="potential benefit" FREQUENCY=2 START=1053 END=1070 LEMMA="POTENTIAL BENEFIT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_29" STRING="potential benefit" FREQUENCY=2 START=1840 END=1857 LEMMA="POTENTIAL BENEFIT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_30" STRING="potential benefit of a multi-step" FREQUENCY=1 START=1840 END=1873 LEMMA="MULTI-STEP POTENTIAL BENEFIT" LEMMA_FREQUENCY=1 HEAD_TERM="potential benefit" HEAD_LEMMA="POTENTIAL BENEFIT"
TERM ID="NYU_TERM_31" STRING="rituximab" FREQUENCY=1 START=1152 END=1161 LEMMA="RITUXIMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="scientific community" FREQUENCY=1 START=1436 END=1456 LEMMA="SCIENTIFIC COMMUNITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="side effects" FREQUENCY=1 START=868 END=880 LEMMA="SIDE EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="systemic disease" FREQUENCY=1 START=87 END=103 LEMMA="SYSTEMIC DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="targeted therapies" FREQUENCY=1 START=1080 END=1098 LEMMA="TARGETED THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="therapeutical approach" FREQUENCY=1 START=1475 END=1497 LEMMA="THERAPEUTICAL APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="vasculitis" FREQUENCY=1 START=150 END=160 LEMMA="VASCULITI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="vessel immune-complex" FREQUENCY=1 START=119 END=140 LEMMA="VESSEL IMMUNE-COMPLEX" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="viral eradication" FREQUENCY=1 START=339 END=356 LEMMA="VIRAL ERADICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="viral origin" FREQUENCY=1 START=181 END=193 LEMMA="VIRAL ORIGIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="viral replication" FREQUENCY=1 START=498 END=515 LEMMA="VIRAL REPLICATION" LEMMA_FREQUENCY=1
